Over the past decade, the IP Forefront Pharma Forum (IFPF) has grown into the most influential and forward-thinking annual event in the field of Pharma IP, both in China and globally. From September 17-19, 2025, we are delighted to host the 10th IP ForeFront Pharma Forum in Shanghai. This year's forum will address the critical theme: "Developing IP Strategy for Global Pharma Markets". IFPF serves as a testament to the collective growth of countless IP professionals, consistently bringing together industry expertise over the past decade. At this significant juncture, we sincerely invite all practioners dedicated to pharma innovation and IP development to join us in reflecting on our journey together, inspiring fresh perspectives, and seizing new opportunities within the pharma sector.
A decade of dedicated effort, moving forward with recognized achievements. IFPF 2025 serves as a vital platform bringing together top industry expertise and driving innovation within the sector, designed to help participants expand their high-level networks and connect with industry resources.
IFIF 2025 will help you understand
• Patent examination and authorization under China's patent reexamination and invalidation system over the past four decades: standards and evolution
• The implementation of patent linkage and drug trial data protection systems: impacts and developments
• Global biotech and pharmaceutical enterprises' patent deployment in the emerging field of Nuclear Pharmacy: challenges and opportunities.
• The significance of strategic planning of IP for pharma companies to achieve sustainable development in the European market.
• Invalidity strategies for biotech and pharmaceutical patents in China under a strict protection regime and the determination of priority rights.
• Observations on invalidation cases of the United States Patent Trial and Appeal Board (PTAB)
• How to effectively utilize priority applications, choose appropriate patent application routes, and develop robust patent layouts.
• The pivotal role of Chinese companies in global biotech and pharmaceutical innovation: IP and licensing transactions.
• The impact of geopolitics and the new Sino-American landscape on licensing transactions in the biotech and pharmaceutical industry.
• IP considerations and challenges in the biotech and pharmaceutical NewCo model.
• Opportunities and challenges for innovative and generic drug companies in China in the context of the patent cliffs and the "three-pillar system".
• Incorporating the Unified Patent Court (UPC) into global patent strategies: an overview of UPC patent litigation.
• Adapt to the evolving external regulatory environment in biotech and pharma sector and Addressing cross-jurisdictional patent challenges.
• Patent protection in emerging pharma markets of Japan, South Korea, India, and Latin America: opportunities and challenges.
Benefits of Attending
• Unique opportunity to raise your profile and showcase your expertise of your organization in Pharma IP area
• Enhancing and establish your partnerships with In-house counsel and industry peers globally to protect your patents and market exclusivity
• Catch up the global pharma IP landscape and trends to build your strategies to adapt it
• Exploring the opportunities of China’s pharmaceutical market and its impact on global innovation system
• Branding your IP services by in-depth conversation,speaking and exhibition booth in front of global pharma IP professionals throughout this three days pharma IP focused summit
• Getting Insights from leading in-house IP counsel, patent prosecutors and litigators, government officials and policy experts from around the world on latest and hottest pharma IP issues facing IP professions today
• Arranging meetings with participants during the conference (Pre-Conference workshops, Tea break, Cocktail parties and Lunches )by using IFPF 2023 online networking system
